000078 ST海王生物
按盤價 
1.450 -0.160 (-9.938%)
1.450 -0.160 (-9.938%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 11,299,187 | -21.05% | 26,667,709 | 30,317,288 | 36,418,770 | 37,834,859 | |
| 減：營業總成本 | 11,377,512 | -20.35% | 26,741,852 | 30,630,058 | 36,503,984 | 37,782,459 | |
| 其中:營業成本 | 10,249,847 | -21.03% | 24,209,623 | 27,444,707 | 32,865,445 | 34,045,035 | |
| 財務費用 | 226,319 | -24.31% | 613,669 | 806,282 | 943,621 | 905,212 | |
| 資產減值損失 | (8,447) | -411.51% | (126,427) | (518,749) | (962,355) | (550,406) | |
| 公允價值變動收益 | 2,498 | 3,420.74% | 11,995 | 6,384 | 17,752 | 56,847 | |
| 投資收益 | (36,895) | -141.53% | 8,921 | 11,147 | (45,418) | (143,505) | |
| 其中：對聯營企業和合營企業的投資收益 | (1,308) | -522.30% | 5,869 | 4,318 | (26,996) | (106,917) | |
| 營業利潤 | (174,926) | -238.02% | (504,929) | (1,062,938) | (1,468,030) | (854,588) | |
| 利潤總額 | (174,669) | -231.66% | (499,300) | (1,081,694) | (1,458,474) | (853,160) | |
| 減：所得稅費用 | 27,732 | -59.13% | 53,256 | 85,617 | 260,559 | 138,290 | |
| 淨利潤 | (202,401) | -412.24% | (552,556) | (1,167,311) | (1,719,033) | (991,450) | |
| 減：非控股權益 | 1,551 | -95.32% | 10,504 | 26,104 | (29,088) | 35,519 | |
| 股東淨利潤 | (203,952) | -743.75% | (563,060) | (1,193,415) | (1,689,945) | (1,026,969) | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.078 | -745.83% | -0.214 | -0.454 | -0.642 | -0.391 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 0.389 | -44.08% | 0.466 | 0.682 | 1.092 | 1.705 | |
| 審計意見 # | -- | 保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 31/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
